Search

everythinglearnresearchcommunity

for

Search:↓

Two women with darker skin had both frontal hair thinning and skin discoloration.

Hormonal imbalances are a key cause of missed menstrual periods in women.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Most white Spanish women have a widow's peak, and their hairline measurements could help in hair restoration surgery.

Androgen measurements are mostly unnecessary for diagnosing PCOS, except in women with menstrual issues.

The document concludes that advancements in hair restoration surgery have led to more natural results and patient satisfaction, with hope for future improvements in treatment.

An 84-year-old woman's hair loss was due to a rare condition called Leydig cell hyperplasia, which was treated with surgery.

New drug uses show promise but need more research.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

PCOD increases weight but keeps BMI normal in young women.

Early diagnosis of GLPLS is crucial to prevent complications, but scarring alopecia is irreversible.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

PCOS is a genetic disorder affecting women's reproductive health, with treatments focused on symptoms like insulin resistance and fertility.

PCOS has no cure, but treatments can manage symptoms and improve health.

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

AGA causes permanent hair loss; women use 2% minoxidil, men use 1 mg finasteride daily.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Oral lichen planus is not linked to sex hormone levels.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.